Sistema de Salut de Catalunya
Institut Català de la Salut
[Santosh P] Department of Child and Adolescent Psychiatry, Institute of Psychology, Psychiatry and Neuroscience, King’s College London, London, UK. Centre for Interventional Paediatric Psychopharmacology and Rare Diseases, South London and Maudsley NHS Foundation Trust, London, UK. HealthTracker Ltd, Gillingham, Kent, UK. [Cortese S] Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK. Clinical and Experimental Sciences (CNS and Psychiatry), Faculty of Medicine, University of Southampton, Southampton, UK. Solent NHS Trust, Southampton, UK. Hassenfeld Children’s Hospital at NYU Langone, New York University Child Study Center, New York City, NY, USA. Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, UK. [Hollis C] School of Medicine, National Institute for Health Research (NIHR) MindTech Mental Health MedTech Cooperative, NIHR Nottingham Biomedical Research Centre, Institute of Mental Health, Mental Health and Clinical Neurosciences, University of Nottingham, Nottingham, UK. [Bölte S] Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Department of Women’s and Children’s Health, Karolinska Institute and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden. Child and Adolescent Psychiatry, Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden. Curtin Autism Research Group, Curtin School of Allied Health, Curtin University, Perth, WA, Australia. [Daley D] NTU Psychology, School of Social Science, Nottingham Trent University, Nottingham, UK. [Coghill D] Departments of Paediatrics and Psychiatry, University of Melbourne, Melbourne, VIC, Australia. Murdoch Children’s Research Institute, Melbourne, VIC, Australia. Royal Children’s Hospital, Melbourne, Melbourne, VIC, Australia. [Ramos-Quiroga A] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain
Vall d'Hebron Barcelona Hospital Campus
2023-06-27T09:53:58Z
2023-06-27T09:53:58Z
2023-06
Adolescents; COVID-19; Remote assessment
Adolescents; COVID-19; Avaluació a distància
Adolescentes; COVID-19; Evaluación a distancia
The COVID-19 pandemic led ADHD services to modify the clinical practice to reduce in-person contact as much as possible to minimise viral spread. This had far-reaching effects on day-to-day clinical practice as remote assessments were widely adopted. Despite the attenuation of the acute threat from COVID, many clinical services are retaining some remote practices. The lack of clear evidence-based guidance about the most appropriate way to conduct remote assessments meant that these changes were typically implemented in a localised, ad hoc, and un-coordinated way. Here, the European ADHD Guidelines Group (EAGG) discusses the strengths and weaknesses of remote assessment methods of children and adolescents with ADHD in a narrative review based on available data and expert opinions to highlight key recommendations for future studies and clinical practice. We conclude that going forward, despite remote working in clinical services functioning adequately during the pandemic, all required components of ADHD assessment should still be completed following national/international guidelines; however, the process may need adaptation. Social restrictions, including changes in education provision, can either mask or exacerbate features associated with ADHD and therefore assessment should carefully chart symptom profile and impairment prior to, as well as during an ongoing pandemic. While remote assessments are valuable in allowing clinical services to continue despite restrictions and may have benefits for routine care in the post-pandemic world, particular attention must be paid to those who may be at high risk but not be able to use/access remote technologies and prioritize these groups for conventional face-to-face assessments.
Article
Published version
English
Trastorn per dèficit d'atenció amb hiperactivitat; Assistència sanitària; COVID-19 (Malaltia); PSYCHIATRY AND PSYCHOLOGY::Mental Disorders::Neurodevelopmental Disorders::Attention Deficit and Disruptive Behavior Disorders::Attention Deficit Disorder with Hyperactivity; DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections; HEALTH CARE::Health Services Administration::Patient Care Management::Delivery of Health Care; PSIQUIATRÍA Y PSICOLOGÍA::trastornos mentales::trastornos del desarrollo neurológico::trastornos conductuales disruptivos y déficit de atención::trastornos de déficit de atención con hiperactividad; ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus; ATENCIÓN DE SALUD::administración de los servicios de salud::gestión de la atención al paciente::prestación sanitaria
Springer
European Child & Adolescent Psychiatry;32
https://doi.org/10.1007/s00787-023-02148-1
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - VHIR [1655]
